| 000 | 01438 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515120224.0 | ||
| 264 | 0 | _c20080829 | |
| 008 | 200808s 0 0 eng d | ||
| 022 | _a0271-9142 | ||
| 024 | 7 |
_a10.1007/s10875-008-9172-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLopes-da-Silva, Susana | |
| 245 | 0 | 0 |
_aAutoimmunity in common variable immunodeficiency. _h[electronic resource] |
| 260 |
_bJournal of clinical immunology _cMay 2008 |
||
| 300 |
_aS46-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xcomplications |
| 650 | 0 | 4 |
_aAutoimmunity _xgenetics |
| 650 | 0 | 4 | _aBrazil |
| 650 | 0 | 4 |
_aCommon Variable Immunodeficiency _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOpportunistic Infections _xcomplications |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSelf Tolerance _ximmunology |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aRizzo, Luiz Vicente | |
| 773 | 0 |
_tJournal of clinical immunology _gvol. 28 Suppl 1 _gp. S46-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10875-008-9172-9 _zAvailable from publisher's website |
| 999 |
_c17940470 _d17940470 |
||